P3 Health Partners Returns to Nasdaq Compliance After Delisting Notice

P3 Health Partners Inc. filed an 8-K report announcing that the company has returned to compliance with Nasdaq listing requirements. The company previously received a delisting notice on November 28, 2025, for failing to meet Nasdaq's continued listing standards, specifically Nasdaq Listing Rule 5550(b) requirements related to stockholders' equity, market value of listed securities, or net income from continuing operations. On May 20, 2026, Nasdaq staff notified the company that based on its Form 8-K filed on May 15, 2026, P3 Health Partners now complies with Nasdaq Listing Rule 5550(b)(2) and has returned to full compliance with all Nasdaq continued listing requirements. The filing was signed by CFO Leif Pedersen on May 26, 2026.